A fragment-based approach leading to the discovery of inhibitors of CK2a with a novel mechanism of action. (2022)

First Author: Brear P

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1039/d2md00161f

PubMed Identifier: 36426237

Publication URI: http://europepmc.org/abstract/MED/36426237

Type: Journal Article/Review

Volume: 13

Parent Publication: RSC medicinal chemistry

Issue: 11

ISSN: 2632-8682